newsfilter
← Latest News
PR Newswire·

Emmaus Life Sciences to be Delisted from Nasdaq Stock Market Following Hearing

Emmaus Life Sciences, Inc. (Nasdaq: EMMA), a leader in sickle cell disease treatment, announced today that it was informed yesterday that the Nasdaq...